Medicaid Prescription Drug Spending in the 1990s: A Decade of Change
نویسندگان
چکیده
Medicaid spending increased dramatically during the 1990s, driven in part by spending for prescription drugs. From 1990 to 2000, Medicaid drug spending increased from $4.4 billion to over $20 billion, an average annual increase of 16.3 percent. Disabled persons experienced an even greater 20 percent average annual increase. By drug category in 1997 (for 29 States), the highest spending amount was for central nervous system (CNS) drugs, accounting for 17 percent of total Medicaid drug spending. These findings provide information on drug spending for dually eligible beneficiaries to policymakers as they seek to target cost-effective coverage and drug therapies.
منابع مشابه
Data View: Medicaid Spending and Utilization for Central Nervous System Drugs
Prior research has shown that prescription drug spending grew substantially during the decade of the 1990s. This analysis uses 1996 to 1998 State Medicaid Research File (SMRF) fee-for-service (FFS) data for 29 participating States to provide insight into the factors driving this growth. The analysis examines cost variation by census region, State, Medicaid basis of eligibility, and therapeutic ...
متن کاملDrug coverage for Medicare beneficiaries: why protection may be in jeopardy.
F ollowing a period of growth over the last decade, trends suggest that Medicare beneficiaries access to affordable prescription drug benefits has begun to decline. Since the late 1990s, the engines that had been driving that growthemployer health plans and Medicare HMOshave been offering increasingly less generous benefits to fewer people.There is no evidence that the private market or curr...
متن کاملAnnual medical spending attributable to obesity: payer-and service-specific estimates.
In 1998 the medical costs of obesity were estimated to be as high as $78.5 billion, with roughly half financed by Medicare and Medicaid. This analysis presents updated estimates of the costs of obesity for the United States across payers (Medicare, Medicaid, and private insurers), in separate categories for inpatient, non-inpatient, and prescription drug spending. We found that the increased pr...
متن کاملMedicaid prescription drug coverage: state efforts to control costs.
This paper provides a brief summary of the Medicaid prescription drug benefit. It explains the mechanisms being used by states to control their prescription drug spending within the Medicaid program. The paper also highlights some of the concerns that have been expressed with these mechanisms and the litigation that has been initiated in several states as a result of these efforts. It takes a c...
متن کاملData View: Estimates of Dual and Full Medicaid Benefit Dual Enrollees, 1999
There is a clear need to develop better estimates of dual (Medicare and Medicaid) enrollees and the subpopulation of dual enrollees who receive full Medicaid benefits. Dual enrollees that may receive full Medicaid benefits include: qualified Medi-care beneficiaries (QMBs), specified low-income Medicare beneficiaries (SLMBs), and other dual beneficiaries—a group that includes medically needy/spe...
متن کامل